CN1680252A - C60 trans-succinate with biologic activity and its synthesis - Google Patents

C60 trans-succinate with biologic activity and its synthesis Download PDF

Info

Publication number
CN1680252A
CN1680252A CN 200510023797 CN200510023797A CN1680252A CN 1680252 A CN1680252 A CN 1680252A CN 200510023797 CN200510023797 CN 200510023797 CN 200510023797 A CN200510023797 A CN 200510023797A CN 1680252 A CN1680252 A CN 1680252A
Authority
CN
China
Prior art keywords
trans
succinate
dibromo
derivative
succinic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510023797
Other languages
Chinese (zh)
Other versions
CN1331836C (en
Inventor
林阳辉
蔡瑞芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fudan University
Original Assignee
Fudan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fudan University filed Critical Fudan University
Priority to CNB2005100237978A priority Critical patent/CN1331836C/en
Publication of CN1680252A publication Critical patent/CN1680252A/en
Application granted granted Critical
Publication of CN1331836C publication Critical patent/CN1331836C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

C60 fumarate with biological activity and its synthesis are disclosed. It is carried out by C602- anion reacting with 1,2-dibromo diacid sodium in butylenes oxide solution, and obtaining C60 derivative-C60 fumarate with polar solvent dissolution. Its advantages include high-selectivity additive reaction, non-toxic, to inhibit growth of liver cancer, and to prepare anti-tumor medicine.

Description

A kind of C of biologically active 60Trans-succinate and synthetic method thereof
Technical field
The invention belongs to inorganic-organic hybrid material technology field, be specifically related to a kind ofly can be dissolved in polar solvent, and the C of biologically active 60Trans-succinate and synthetic method thereof.
Technical background
Since 1993 (S.H.Friedman et al., J.Am.Chem.Soc.1993,115,6506.) such as Friedman synthesize the inhibited water-soluble C of HIV (human immunodeficiency virus) proteolytic enzyme 60Since the derivative, people recognize C 60([60] soccerballene) can biological chemistry and medical aspect have bright prospects.But for a long time because C 60Only be dissolved in the nonpolar and weak polar solvent such as benzene, toluene and dithiocarbonic anhydride water insoluble, tetrahydrofuran (THF) isopolarity solvent, thereby the synthetic C that is dissolved in polar solvent (as water etc.) 60Derivative is C 60In biological chemistry, key in medical applications aspect particularly; While C 60Itself have very big electronegativity, the too high pair cell of electronegativity easily produces the bio-toxicity effect.People make C by chemically modified 60The electronegativity of derivative significantly descends, and reduces their intrinsic bio-toxicities (Zhu Z et al., Biochemistry2003,42,1326; McGovern S.L.et al., J.Med.Chem.2002,45,1712; Chiang, L.Y.etal., J.Chem.Soc., Chem.Commun.1994,2675; Wharton T.et al., Tetrhedron Lett.2001,42 (31), 5159.).The derivative of [60] soccerballene of finding to contain porphyrin ring if any the people is to serum biologically active that self-Immunological diseases patient is arranged (Panagiota S.et al., Tetrahedron 2004,60,2823.); Use water-soluble C 60Derivative is made the artificial lipoid film with similar bioactive film, and usefulness such as Yamakoshi are dissolved in the C of the polyvinylpyrrolidone aqueous solution 60Carried out the hemolytic action experiment, found blood is had no effect; Wilson etc. have done many work in this respect, as (Hungerb ü hler H.et al., J.Am.Chem.Soc.1993,115,3386 such as influence of the phosphatic fullerene derivate of synthetic to the bone tissue growth; Murakami H.et al., J.Am.Chem.Soc.1996,118,4484; Yamakoshi Y.N.et al., J.Chem.Soc.Chem.Commun.1994, (4), 517; Wilson L.J.etal., Bioorg.Med.Chem.2002,10 (6), 1991.).
Summary of the invention
The objective of the invention is to propose a kind of C that can be dissolved in polar solvent, biologically active 60Derivative and synthetic method thereof.
The C that the present invention proposes 60Derivative is at C 60Introduce the C of the generation of polar group carboxyl on the outer spheroid 60Trans-succinate, its structural formula is:
According to C 60Character itself will prepare and is dissolved in the particularly C of water of polar solvent 60Derivative generally has two kinds of methods: the one, and at C 60Introduce polar group on the outer spheroid, the 2nd, make soluble substance comprise C 60Molecule.The present invention passes through at C 60Introduce the polar group carboxyl on the outer spheroid, make C 60Generate the novel derivative---C of water soluble, tetrahydrofuran (THF), acetone isopolarity solvent 60Trans-succinate.The selectivity of this reaction is very high, single additive derivative almost 100%; Productive rate is also higher, can reach about 80%.This all helps carrying out C 60The test of the biological activity test of derivative.Its biological activity test also demonstrates good result, has potential application foreground aspect the property of medicine such as inhibition and elimination fungi, tumour cell.
The C that the present invention proposes 60Anti-succinic carboxylic acid synthetic method is as follows:
Under nitrogen atmosphere, use C 60, potassium, 1-methylnaphthalene and tetrahydrofuran solution, reacted synthetic C 2-3 hour 60 2-Negatively charged ion; Then, add and the isopyknic normal hexane of tetrahydrofuran solution, put into the refrigerator below-10 ℃, time 5-7 days; Take out then, mother liquor is separated, add 1 again, 2-dibromo-succinic acid sodium under 50~70 ℃, refluxes and stirred 5-8 hour; Cool to room temperature, centrifugal, vacuum is taken out and is desolvated; Use washing with acetone, vacuum is drained again, gets brown-black powder, is C 60The trans-succinate derivative; In the above-mentioned reaction, C 60The mol ratio of/potassium is 1: 2, C 60/ 1, the mol ratio of 2-dibromo-succinic acid sodium is 1: 1.Through the wave spectrum illness that has not attacked the vital organs of the human body, the structural formula of products therefrom is: C 60(CHCOOH) 2
Among the present invention, 1, the synthetic method of 2-dibromo-succinic acid sodium is as follows: according to classical organic chemical reactions, earlier with FUMARIC ACID TECH GRADE and sodium hydroxide solution reaction, after the salinization itself and liquid bromine reaction can be obtained crude product, promptly obtain high-purity dibromo-succinic acid sodium salt by carbon tetrachloride extraction and recrystallization again.1, the molecular structural formula of 2-dibromo-succinic acid sodium is as follows:
In the above-mentioned synthetic method, should earlier anti-succinic carboxylic acid be converted into sodium salt fully, otherwise the H of carboxylic acid +More active relatively, easy elder generation and C 60The negative ion reaction generates hydride, thus the product that can not get expecting.And with the trans-succinate sodium salt directly and C 60React in toluene solution, prove reactionless generation, this may be that the activation energy that reacts is too high relevant.
Showing by the thin plate chromatography, was that single product is C before acidifying 60The trans-succinate disodium salt, this product is water-soluble, is soluble in THF, acetone isopolarity solvent.Show that from the mass spectrum (FD-MS) of compound product C is arranged 60The molecular ion peak 833 of trans-succinate, the absorption peak of infrared spectra mainly contain (KBr compressing tablet): 3437,2924,1731,1709,1631,1606,1550,1528,1440,1428,1181,1121,1084,1037,846,656, and 578,528,434 cm -1Deng.Can show that from data they all have C 60Characteristic peak, C is described 60The molecule basket structure is complete substantially; The V of carboxyl C=0At 1731cm -1The place can be pointed out; And-charateristic avsorption band of OH base is 3437,1636cm -1The place can be pointed out; The absorption peak of C-O is 1121cm -1-COO -Absorption peak 1606,1420cm -1The place can be pointed out, and showing has a small amount of sodium salt to exist in the final product.Obtain its visible UV spectrum peak in trichloromethane simultaneously: 245,280,328,405,432nm etc.; This also illustrates C in this derivative 60Cage be kept perfectly substantially, but the functional group of being modified influences the displacement to some extent of the position of characteristic peak; δ 5.41 is the methine protons peak in the hydrogen nuclear magnetic resonance spectrogram.
The present invention is to C 60The trans-succinate derivative has carried out biological activity test.We have done it earlier to Normocellular toxicity test, prove to have no side effect.
Earlier with 3g extractum carnis, 10g peptone, 5g NaCl, 20g agar, 1000mL, PH is that 7.4~7.6 distilled water stirs well the even substratum of promptly making; 5mg C 60The trans-succinate derivative adds DMF and water dissolution, and the scraps of paper soak.The solution of DMF and water soaks with the scraps of paper in addition.
Intestinal bacteria and streptococcus aureus are seeded in the 5mL bacterial liquid substratum, cultivate 12 hours for 37 ℃.
Getting bacteria culture medium 15mL adds in the culture dish, as lower floor.Other gets substratum 50mL and adds above-mentioned cultured bacterial liquid substratum 1mL, adds on the lower floor's substratum that has watered, as the upper strata from wherein getting 5mL again.The soaked scraps of paper are placed on above the substratum, cultivate 12 hours for 37 ℃.This compound is to intestinal bacteria and aureus with inhibition and other paired observation result such as table 1.
Table 1 sample is to the biological activity test of fungi
Intestinal bacteria Streptococcus aureus
????C 60Anti-succinic carboxylic acid ????+ ????-
Streptomycin sulphate ????+ ????+
DMF+ water ????- ????-
(+expression suppresses microorganism growth, and-expression does not suppress microorganism growth)
The solution of DMF and water is to all unrestraint effects of growth of intestinal bacteria and streptococcus aureus, thereby got rid of the effect of solvent; C 60Anti-succinic carboxylic acid has restraining effect to intestinal bacteria growths, but to the growth unrestraint effect of streptococcus aureus.
The present invention also done this compound under different concns to the bioactive test of liver cancer cell: with C 60Anti-succinic carboxylic acid derivative 2mg dissolves in the 2mL deionized water, gets 100 μ L and 400 μ L nutrient solutions are made into 500 μ L, and every hole is got this solution 100,50,10,5 μ L respectively and all is made into 200 μ L, and test is to the restraining effect of liver cancer cell growth.Result such as table 2.
Table 2 sample is to the biological activity test of liver cancer cell
* the data in the table are the fluorescence absorbancy
Experiment shows, shows liver cancer cell growth is had weak restraining effect under 5 μ L, 10 μ L concentration, do not show restraining effect under other concentration, illustrates that this derivative has snob effect.
Biological activity test shows that this derivative has using value at inhibition fungal growth medicine and medicine for treating tumor object space face.
Embodiment
C 60Synthesizing of trans-succinate derivative
Embodiment 1:
Under nitrogen atmosphere, with 180mg (0.251mmol) C 60, 20mg (0.50mmol) potassium, 1mL 1-methylnaphthalene, 20ml tetrahydrofuran solution, the synthetic C of reaction 60 2-Negatively charged ion after 3 hours, adds normal hexane, after mother liquor is separated, adds 80mg (0.50mmol) 1, and 2-dibromo-succinic acid sodium down, refluxes and stirred 8 hours about 60 ℃.Cooling, centrifugal, vacuum is taken out and is desolvated; Add dilute hydrochloric acid, stir half a day.Centrifugal, vacuum is drained, and uses washing with acetone, and vacuum is drained again, gets the 170mg brown-black powder, is C 60Trans-succinate derivative, productive rate are 81%.
Embodiment 2:
Under nitrogen atmosphere, with 181mg (0.251mmol) C 60, 21mg (0.54mmol) potassium, 1mL 1-methylnaphthalene, 20ml tetrahydrofuran solution, the synthetic C of reaction 60 2-Negatively charged ion after 2 hours, adds normal hexane, after mother liquor is separated, adds 79.9mg (0.50mmol) 1, and 2-dibromo-succinic acid sodium down, refluxes and stirred 5 hours about 50 ℃.Cooling, centrifugal, vacuum is taken out and is desolvated; Add dilute hydrochloric acid, stir half a day.Centrifugal, vacuum is drained, and uses washing with acetone, and vacuum is drained again, gets the 121mg brown-black powder, is C 60Trans-succinate derivative, productive rate are 57%.
Embodiment 3:
Under nitrogen atmosphere, with 179mg (0.249mmol) C 60, 20mg (0.50mmol) potassium, 1mL 1-methylnaphthalene, 20ml tetrahydrofuran solution, the synthetic C of reaction 60 2-Negatively charged ion after 3 hours, adds normal hexane, after mother liquor is separated, adds 82mg (0.51mmol) 1, and 2-dibromo-succinic acid sodium down, refluxes and stirred 8 hours about 70 ℃.Cooling, centrifugal, vacuum is taken out and is desolvated; Add dilute hydrochloric acid, stir half a day.Centrifugal, vacuum is drained, and uses washing with acetone, and vacuum is drained again, gets the 179mg brown-black powder, is C 60Trans-succinate derivative, productive rate are 85%.

Claims (4)

1, a kind of C of biologically active 60Derivative is characterized in that at C 60The C that introduces the polar group carboxyl on the outer spheroid and generate 60Trans-succinate, structural formula is:
2, a kind of C 60The synthetic method of trans-succinate is characterized in that concrete steps are as follows: under nitrogen atmosphere, use C 60, potassium, 1-methylnaphthalene and tetrahydrofuran solution reacted 2-3 hour, synthetic C 60 2-Negatively charged ion; Then, add and the isopyknic normal hexane of tetrahydrofuran solution, put into the refrigerator below-10 ℃, time 5-7 days; Take out then, mother liquor is separated, add 1 again, 2-dibromo-succinic acid sodium under 50~70 ℃, refluxes and stirred 5-8 hour; Cool to room temperature, centrifugal, vacuum is taken out and is desolvated; Use washing with acetone, vacuum is drained again, gets brown-black powder, is C 60The trans-succinate derivative; In the above-mentioned reaction, C 60The mol ratio of/potassium is 1: 2, C 60/ 1, the mol ratio of 2-dibromo-succinic acid sodium is 1: 1.
3, synthetic method according to claim 2, it is characterized in that described 1, the synthetic method of 2-dibromo-succinic acid sodium is as follows: earlier with FUMARIC ACID TECH GRADE and sodium hydroxide solution reaction, after the salinization itself and liquid bromine reaction can be obtained crude product, promptly obtain high-purity dibromo-succinic acid sodium salt by carbon tetrachloride extraction and recrystallization again.
4, C 60The application of trans-succinate in preparation inhibition fungal growth medicine and medicine for treating tumor thing.
CNB2005100237978A 2005-02-03 2005-02-03 C60 trans-succinate with biologic activity and its synthesis Expired - Fee Related CN1331836C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100237978A CN1331836C (en) 2005-02-03 2005-02-03 C60 trans-succinate with biologic activity and its synthesis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100237978A CN1331836C (en) 2005-02-03 2005-02-03 C60 trans-succinate with biologic activity and its synthesis

Publications (2)

Publication Number Publication Date
CN1680252A true CN1680252A (en) 2005-10-12
CN1331836C CN1331836C (en) 2007-08-15

Family

ID=35067127

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100237978A Expired - Fee Related CN1331836C (en) 2005-02-03 2005-02-03 C60 trans-succinate with biologic activity and its synthesis

Country Status (1)

Country Link
CN (1) CN1331836C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE529056C2 (en) 2005-07-08 2007-04-17 Plasma Surgical Invest Ltd Plasma generating device, plasma surgical device and use of a plasma surgical device
SE529058C2 (en) 2005-07-08 2007-04-17 Plasma Surgical Invest Ltd Plasma generating device, plasma surgical device, use of a plasma surgical device and method for forming a plasma

Also Published As

Publication number Publication date
CN1331836C (en) 2007-08-15

Similar Documents

Publication Publication Date Title
JPS5925599B2 (en) New physiologically active substance monacolin K and its production method
CN101591288B (en) Cytochalasin compounds and preparation method and application thereof
CN109722457B (en) Method for preparing vitamin K2 by using magnetic field to assist flavobacterium liquid fermentation
CN102766184A (en) Protopanoxadiol peroxide derivatives as well as preparation method and application thereof
CN1331836C (en) C60 trans-succinate with biologic activity and its synthesis
CN102816717B (en) Staphylococcus cohnii and method for preparing 5-aminolevulinic acid by using staphylococcus cohnii
CN102741243B (en) Novel compound amycolatopsis derivative, and production process and use of same
CN110218744A (en) A method of bent ground acid is prepared by microbial fermentation
JP3030896B2 (en) WB968 substance group and production method thereof
JP2879394B2 (en) Benzanthracene derivative, antitumor agent containing the derivative and method for producing the same
JPH08127583A (en) Substance fo-2047 and its production
JP2003503416A (en) New compound
JPS6229987A (en) Novel antibiotic substance al-rc262 and production thereof
JP4221098B2 (en) Novel antibiotics Meleolide K, L and M and methods for their production
CN114224876A (en) Preparation method of sesterterpene compounds and application of sesterterpene compounds in resisting clinical drug-resistant bacteria
JP2000086627A (en) Antibacterial substance be-54476 and its production
JP2001055386A (en) Antibiotic tubelactomicin b, d and e, and production thereof
WO1993014216A1 (en) Process for producing chitin and chitosan from dermatophyte
JPH0585998A (en) New compounds ca39-a and ca39-b, their use and production
JPH0429995A (en) New antibiotic substance wf3010 and its production
JPH03240496A (en) New physiologically active substance kdc 165
JPH03232887A (en) New substance bk 97, use thereof and production thereof
JPH05255389A (en) Cyclopeptide compound
JPH09511902A (en) WF15604 substance
WO2003045982A1 (en) Antibiotics fki-9739 and process for producing the same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070815

Termination date: 20100203